These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23097886)

  • 1. [The transplant patient at the community health center and the emergency department].
    Westman K; Castedal M; Bennet W; Kornhall B
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1762-5. PubMed ID: 23097886
    [No Abstract]   [Full Text] [Related]  

  • 2. Caring for transplant recipients in a nontransplant setting.
    Hoffman FM; Nelson BJ; Drangstveit MB; Flynn BM; Watercott EA; Zirbes JM
    Crit Care Nurse; 2006 Apr; 26(2):53-66, 68-73; quiz 74. PubMed ID: 16565281
    [No Abstract]   [Full Text] [Related]  

  • 3. How can we improve the long-term outcome after pediatric organ transplantation?
    Debray D
    Curr Opin Organ Transplant; 2010 Oct; 15(5):588-9. PubMed ID: 20689434
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes in pediatric solid-organ transplantation.
    LaRosa C; Baluarte HJ; Meyers KE
    Pediatr Transplant; 2011 Mar; 15(2):128-41. PubMed ID: 21309962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes and quality of life after intestine transplantation.
    Sudan D
    Curr Opin Organ Transplant; 2010 Jun; 15(3):357-60. PubMed ID: 20445450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection in solid-organ transplant recipients.
    Fishman JA
    N Engl J Med; 2007 Dec; 357(25):2601-14. PubMed ID: 18094380
    [No Abstract]   [Full Text] [Related]  

  • 7. Infectious complications of immunosuppressive medications in organ transplant recipients.
    Green M; Michaels MG
    Pediatr Infect Dis J; 2007 May; 26(5):443-4. PubMed ID: 17468657
    [No Abstract]   [Full Text] [Related]  

  • 8. Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.
    Helfrich M; Ison MG
    Transpl Infect Dis; 2015 Oct; 17(5):627-36. PubMed ID: 26228653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic immunosuppression in solid organ transplantation: a Canadian perspective.
    Harrison JJ; Schiff JR; Coursol CJ; Daley CJ; Dipchand AI; Heywood NM; Keough-Ryan TM; Keown PA; Levy GA; Lien DC; Wichart JR; Cantarovich M
    Transplantation; 2012 Apr; 93(7):657-65. PubMed ID: 22267158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current world literature.
    Curr Opin Organ Transplant; 2010 Oct; 15(5):657-69. PubMed ID: 20844432
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complications of immunosuppressive therapy in organ transplantation].
    Jørgensen KA; Dieperink H; Kirkegaard P
    Ugeskr Laeger; 2003 Dec; 165(49):4727-9. PubMed ID: 14708378
    [No Abstract]   [Full Text] [Related]  

  • 12. Indirect effects of CMV in the solid organ transplant patient.
    Paya CV
    Transpl Infect Dis; 1999; 1 Suppl 1():8-12. PubMed ID: 11565588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transplant patient monitoring].
    Caillard S; Moulin B
    Rev Prat; 2007 Feb; 57(3):299-308. PubMed ID: 17578031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset diabetes after transplantation: risk factors and clinical impact.
    Räkel A; Karelis AD
    Diabetes Metab; 2011 Feb; 37(1):1-14. PubMed ID: 21295510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of over-immunosuppression.
    Budde K; Matz M; Dürr M; Glander P
    Clin Pharmacol Ther; 2011 Aug; 90(2):316-22. PubMed ID: 21716278
    [No Abstract]   [Full Text] [Related]  

  • 16. Refining the definition and management of high-risk organ transplant recipients.
    Hricik DE
    Curr Opin Organ Transplant; 2009 Dec; 14(6):634-5. PubMed ID: 19920762
    [No Abstract]   [Full Text] [Related]  

  • 17. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
    Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
    Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring of the liver transplant].
    Giostra E; Roch F; Mentha G
    Rev Med Suisse Romande; 1994 Sep; 114(9):773-9. PubMed ID: 7939108
    [No Abstract]   [Full Text] [Related]  

  • 19. Center effects in renal transplantation.
    Ogura K; Cecka JM
    Clin Transpl; 1991; ():245-56. PubMed ID: 1820120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of opportunistic infections in solid-organ transplantation.
    Chiu LM; Domagala BM; Park JM
    Prog Transplant; 2004 Jun; 14(2):114-29. PubMed ID: 15264456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.